Botulinum toxin type A in post-stroke upper limb spasticity

References

• Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, eds. Spasticity: Disordered Motor Control. Chicago: Year Book Medical Publishers, 1980:485-94
   Google Scholar
• Brashear A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002;347:395-400
   PubMed Web of Science ®Google Scholar
• Turner-Stokes L, Ward A. Guidelines for the use of botulinum toxin (BTX) in the management of spasticity in adults. London: Royal College of Physicians, 2002
   Google Scholar
• Bogey RA, Geis CC, Bryant PR, et al. Stroke and Neurodegenerative Disorders. 3. Stroke: Rehabilitation Management. Arch Phys Med Rehabil 2004;85(Suppl 1):S15-20
   Google Scholar
• Ward AB. A summary of spasticity management -- a treatment algorithm. Eur J Neurol 2002;9(Suppl 1):48-52
   PubMed Web of Science ®Google Scholar
• Childers MK, Brashear A, Jozefczyk P, et al. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke. Arch Phys Med Rehabil 2004;85:1063-9
   PubMed Web of Science ®Google Scholar
• Simpson DM, Alexander DN, O'Brien CF, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996;46:1306-10
   PubMed Web of Science ®Google Scholar
• Gordon MF, Brashear A, Elovic E, et al. Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke. Neurology 2004;63:1971-3
   PubMed Web of Science ®Google Scholar
• Elovic EP, Brashear A, Kaelin D, et al. Repeated treatments with botulinum toxin type A produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients. Arch Phys Med Rehabil 2008;89:799-806
   PubMed Web of Science ®Google Scholar
• Rosales RL, Chua-Yap AS. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. J Neural Transm 2008;115:617-23
   PubMed Web of Science ®Google Scholar
• Simpson DM, Gracies JM, Graham HK, et al. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Neurology 2008;70:1691-8
   PubMed Web of Science ®Google Scholar
• Elia AE, Filippini G, Calandrella D, et al. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review. Mov Disord 2009; 24:801-12
   PubMed Web of Science ®Google Scholar
• Bohannon RW, Smith MB. Interrater reliability of a Modified Ashworth Scale of muscle spasticity. Phys Ther 1987;67:206-7
   PubMed Web of Science ®Google Scholar
• Brashear A, Zafonte R, Corcoran M, et al. Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity. Arch Phys Med Rehabil 2002;83:1349-54
   PubMed Web of Science ®Google Scholar
• Brin MF. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Muscle Nerve Suppl 1997;6:S208-20
   Google Scholar
• Allergan K.K. Clinical trial of AGN191622 (Botulinum toxin A) in post-stroke upper limb spasticity. Tokyo: Allergan K.K.; 2005. Internal study report AGN191622-910
   Google Scholar
• Matthews JNS, Altman DG, Campbell MJ, et al. Analysis of serial measurements in medical research. BMJ 1990;300:230-5
   PubMed Web of Science ®Google Scholar
• Liu C, A Li Wan Po, Blumhardt LD. ‘Summary measure’ statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64:726-9
   PubMed Web of Science ®Google Scholar
• Pham B, Cranney A, Boers M, et al. Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials. J Rheumatol 1999;26:712-16
   PubMed Web of Science ®Google Scholar
• Smith SJ, Ellis E, White S, et al. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000;14:5-13
   PubMed Web of Science ®Google Scholar
• Turkel CC, Bowen B, Liu J, et al. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity. Arch Phys Med Rehabil 2006;87:786-92
   PubMed Web of Science ®Google Scholar
• Simpson DM, Gracies JM, Yablon SA, et al. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study. J Neurol Neurosurg Psychiatry 2009;80:380-5
   PubMed Web of Science ®Google Scholar
• Sun SF, Hsu CW, Sun HP, et al. Combined Botulinum toxin Type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabil Neural Repair 2010;24:34-41
   PubMed Web of Science ®Google Scholar
• Kaji R, Osako Y, Suyama K, et al. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial. J Neurol 2010: published online 1 April 2010, doi:10.1007/s00415-010-5526-3
   Google Scholar
• Anderson TJ, Rivest J, Stell R, et al. Botulinum toxin treatment of spasmodic torticollis. J R Soc Med 1992;85:524-9
   PubMed Web of Science ®Google Scholar
• Brin MF, Blitzer A. Botulinum toxin: dangerous terminology errors. J R Soc Med 1993;86:493-4
   PubMed Web of Science ®Google Scholar
• Marsden CD. Botulinum toxin: dangerous terminology errors. Reply. J R Soc Med 1993;86:494
   PubMed Web of Science ®Google Scholar
• Chapman MA, Barron R, Tanis DC, et al. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia. Clin Ther 2007;29:1325-37
   PubMed Web of Science ®Google Scholar
• Wenzel R, Jones D, Borrego JA. Comparing two botulinum toxin type A formulations using manufacturers' product summaries. J Clin Pharm Ther 2007;32:387-402
   PubMed Web of Science ®Google Scholar
• Harper L. Botulinum toxin A – when is a unit not a unit?. J Urol 2009;181:414-15
   PubMed Web of Science ®Google Scholar
• Botox® Product Information (Revised October 2006, USA)
   Google Scholar